Single-center experience on endovascular reconstruction of traumatic internal carotid artery dissections

2012 ◽  
Vol 72 (1) ◽  
pp. 216-221 ◽  
Author(s):  
José E. Cohen ◽  
John M. Gomori ◽  
Eyal Itshayek ◽  
Sergey Spektor ◽  
Yigal Shoshan ◽  
...  
2019 ◽  
Vol 182 ◽  
pp. 136-141
Author(s):  
Auricelio B. Cezar-Junior ◽  
Ubiratan Alves da Silva Viturino ◽  
Eduardo Vieira de Carvalho ◽  
Igor Vilela Faquini ◽  
Nivaldo S. Almeida ◽  
...  

2017 ◽  
Vol 57 (5) ◽  
pp. 231-237 ◽  
Author(s):  
Kensuke SUZUKI ◽  
Ryotaro SUZUKI ◽  
Tomoji TAKIGAWA ◽  
Nobuyuki SHIMIZU ◽  
Yoshiyuki MATSUMOTO ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Anil Tanburoglu ◽  
Cagatay Andic

Background and Purpose: Blood Blister-like aneurysms (BBAs) of the internal carotid artery (ICA) are rare entities of cerebral aneurysms. FD use in acutely ruptured aneurysms, timing of treatment and antiplatelet regimen are main debate topics in clinical practice when the treatment decision is flow diversion. The aim of this study is to report the safety and efficacy of a single-center FD treatment for ruptured BBAs in the early phase of SAH using the SAPT regimen.Material and Method: This study involved a retrospective analysis of a prospectively collected database. Records of patients admitted to our clinic and treated by endovascular route on ruptured BBA between January 2013 and December 2020 were reviewed. Ruptured supraclinoid ICA BBAs treated with FD devices with SAPT within 48 h from ictus of SAH are included. BBA of atypical anatomic locations, other endovascular techniques performed, and delayed admissions (>48 h) were excluded from the study. Demographic, clinical and angiographic features of patients and aneurysms, FD types and numbers, periprocedural complications, immediate and follow-up angiographic and clinical outcomes were recorded.Results: A total of six patients with ruptured BBAs treated via FDs within 48 h and used SAPT were included in the study. The mean age was 41.6 years (range from 34 to 45 years), and four of six patients were female. All patients were treated within 48 h after ictus, and the mean treatment day was 1.33 days. One patient received ticagrelor, and five patients received prasugrel as SAPT for one year after treatment. No procedure-related death and rebleeding were recorded. One (16.7 %) treatment responsive procedure-related complication occurred (transient ischemia). Overall good outcome rate was 83.3%. One patient died due to pneumonia. The immediate control angiograms showed complete occlusions of BBAs in one patient (16.6%). The complete occlusion rate was 100 % for five survivors at the control angiogram. The median follow-up was 49.5 months.Conclusion: This single-center experience suggests that early treatment (<2 days) within SAH of ruptured BBAs with FDs using SAPT is safe and effective in terms of clinical and radiological long-term outcomes.


2020 ◽  
Vol 26 (4) ◽  
pp. 433-438
Author(s):  
Yigit Ozpeynirci ◽  
Cristian Capatana ◽  
Johannes Rosskopf ◽  
Bernd L Schmitz ◽  
Gerhard F Hamann ◽  
...  

Background Casper-RX (MicroVention, Aliso Viejo, California, USA) is a dual-layer closed cell stent recently introduced as a carotid artery revascularization device. Although its effectiveness and safety has been proved in elective cases, there are contradictive results regarding its patency in emergency settings. The purpose of the study is to present our single-center experience with the Casper-RX stent in the emergency interventions. Patients and methods Consecutive patients who underwent emergency carotid artery stenting using Casper-RX system with or without additional intracranial thrombectomy between August 2016 and June 2019 at our institution were included. Primary end point was the short-term patency of the carotid stents evaluated before hospital discharge by use of Doppler ultrasonography. Results Twenty-nine procedures performed on 28 patients were included in the study. All stents were patent on final angiograms. Acute stent occlusion was observed only in one case (3.4%) with a spontaneous cervical internal carotid artery dissection the day after the procedure. In 26 (89.6%) cases, an additional intracranial thrombectomy was performed with a successful recanalization rate of 96.1%. Seven adverse events occurred peri-/post-procedural: two cases (6.9%) with iatrogenic dissection of distal cervical internal carotid artery during intracranial thrombectomy, two parenchymal hematoma type 2 (6.8%), and three patients (10.3%) developed massive infarction. Conclusion This study supports the safety and efficacy of the Casper-RX stent in emergency endovascular carotid artery revascularization procedures.


Sign in / Sign up

Export Citation Format

Share Document